Aurinia Pharmaceuticals to Present at the 9th Annual SVB Leerink Global Healthcare Conference
February 21 2020 - 4:05PM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the
“Company”) today announced that Mr. Peter Greenleaf,
President and Chief Executive Officer, will present a corporate
overview at the 9th Annual SVB Leerink Global Healthcare Conference
on Tuesday, February 25, 2019 at 10:00 a.m. ET in New York, NY.
The presentation will be webcast live and accessible via the
investor section of the Aurinia website, www.auriniapharma.com. A
replay will also be archived on the Company website following the
event.
About Aurinia
Aurinia Pharmaceuticals is a late clinical-stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are impacted
by serious diseases with a high unmet medical need. The Company is
currently developing an investigational drug, for the treatment of
lupus nephritis, focal segmental glomerulosclerosis and dry eye
syndrome. The Company’s head office is in Victoria, British
Columbia and focuses its development efforts globally. For further
information, see our website at www.auriniapharma.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200221005283/en/
Investor & Corporate Contact Glenn Schulman, PharmD,
MPH Corporate Communications, Aurinia
gschulman@auriniapharma.com
Media Contact Krystle Gibbs Ten Bridge Communications
krystle@tenbridgecommunications.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2023 to Apr 2024